Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / Class A Common Stock, par value $0.0001 per share
-
Shares outstanding
-
126,273,814
-
Number of holders
-
50
-
Total 13F shares, excl. options
-
3,847,640
-
Shares change
-
-214,419
-
Total reported value, excl. options
-
$12,393,195
-
Value change
-
-$1,227,774
-
Number of buys
-
25
-
Number of sells
-
-18
-
Price
-
$3.23
Significant Holders of Organogenesis Holdings Inc. - Class A Common Stock, par value $0.0001 per share (ORGO) as of Q1 2020
57 filings reported holding ORGO - Organogenesis Holdings Inc. - Class A Common Stock, par value $0.0001 per share as of Q1 2020.
Organogenesis Holdings Inc. - Class A Common Stock, par value $0.0001 per share (ORGO) has 50 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3,847,640 shares
of 126,273,814 outstanding shares and own 3% of the company stock.
Largest 10 shareholders include Prosight Management, LP (672,275 shares), BlackRock Inc. (651,085 shares), GRANAHAN INVESTMENT MANAGEMENT INC/MA (285,990 shares), VANGUARD GROUP INC (262,188 shares), GEODE CAPITAL MANAGEMENT, LLC (242,105 shares), NORTHERN TRUST CORP (205,611 shares), HUSSMAN STRATEGIC ADVISORS, INC. (200,000 shares), STATE STREET CORP (171,788 shares), BANK OF MONTREAL /CAN/ (124,106 shares), and CHARLES SCHWAB INVESTMENT MANAGEMENT INC (123,094 shares).
This table shows the top 50 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.